tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

INCY Stock Latest News

Incyte price target lowered to $84 from $92 at Oppenheimer
The FlyIncyte price target lowered to $84 from $92 at Oppenheimer
1d ago
INCY
Piper likes Incyte’s Escient acquisition, looking for more deals
PremiumThe Fly
Piper likes Incyte’s Escient acquisition, looking for more deals
2d ago
INCY
Roblox upgraded, Qualcomm initiated: Wall Street’s top analyst calls
PremiumThe Fly
Roblox upgraded, Qualcomm initiated: Wall Street’s top analyst calls
2d ago
ACI
MDB
Roblox upgraded, Qualcomm initiated: Wall Street’s top analyst calls
PremiumThe Fly
Roblox upgraded, Qualcomm initiated: Wall Street’s top analyst calls
2d ago
ACI
MDB
Incyte to acquire Escient Pharmaceuticals for $750M
PremiumThe Fly
Incyte to acquire Escient Pharmaceuticals for $750M
2d ago
INCY
Incyte initiated with a Neutral at Cantor on ‘lukewarm view’ of pipeline
PremiumThe FlyIncyte initiated with a Neutral at Cantor on ‘lukewarm view’ of pipeline
2d ago
INCY
Incyte initiated with a Neutral at Cantor Fitzgerald
PremiumThe Fly
Incyte initiated with a Neutral at Cantor Fitzgerald
2d ago
INCY
Incyte gets payment from CMS Skinhealth for povorcitinib commercialization
PremiumThe Fly
Incyte gets payment from CMS Skinhealth for povorcitinib commercialization
24d ago
INCY
Incyte, CMS enter collaboration, license agreement for povorcitinib in China
PremiumThe Fly
Incyte, CMS enter collaboration, license agreement for povorcitinib in China
24d ago
INCY
Incyte participates in a conference call with JPMorgan
PremiumThe Fly
Incyte participates in a conference call with JPMorgan
1M ago
INCY
Incyte participates in a conference call with JPMorgan
PremiumThe Fly
Incyte participates in a conference call with JPMorgan
1M ago
INCY
Incyte price target lowered to $67 from $69 at BofA
PremiumThe Fly
Incyte price target lowered to $67 from $69 at BofA
1M ago
INCY
Incyte to hold a conference call
PremiumThe FlyIncyte to hold a conference call
2M ago
INCY
Incyte to hold a conference call
PremiumThe Fly
Incyte to hold a conference call
2M ago
INCY
Incyte announces new data from Phase 2 study evaluating ruxolitinib cream
PremiumThe Fly
Incyte announces new data from Phase 2 study evaluating ruxolitinib cream
2M ago
INCY
Incyte presents late-breaking data from Phase 2 trial evaluating povorcitinib
PremiumThe Fly
Incyte presents late-breaking data from Phase 2 trial evaluating povorcitinib
2M ago
INCY
Incyte says FDA grants priority review for axatilimab
PremiumThe Fly
Incyte says FDA grants priority review for axatilimab
2M ago
INCY
SNDX
Block upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Block upgraded, Rivian downgraded: Wall Street’s top analyst calls
2M ago
SQ
BHF
Incyte initiated with a Buy at Jefferies
PremiumThe Fly
Incyte initiated with a Buy at Jefferies
2M ago
INCY
Incyte price target raised to $64 from $58 at BMO Capital
PremiumThe FlyIncyte price target raised to $64 from $58 at BMO Capital
2M ago
INCY
Incyte price target raised to $65 from $63 at RBC Capital
PremiumThe Fly
Incyte price target raised to $65 from $63 at RBC Capital
2M ago
INCY
Incyte price target raised to $68 from $67 at Stifel
PremiumThe Fly
Incyte price target raised to $68 from $67 at Stifel
2M ago
INCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >